An FDA advisory panel unanimously agreed that Johnson & Johnson MedTech's V-Wave Ventura interatrial shunt's risks outweigh ...
Johnson & Johnson stock rises on strong earnings, the Halda deal, FDA wins and an upcoming orthopedics spinoff as analysts weigh the outlook.
The company recently announced the acquisition of a biotech with an innovative cancer treatment. Johnson & Johnson had strong Q3 results and reported an important acquisition. Johnson & Johnson 's ( ...
Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Passive Income Stocks to Buy Right Now. On November 12, Scotiabank’s Louise Chen began coverage of ten large-cap biopharma companies and ...
Johnson & Johnson plans to spin off its orthopedics business into a standalone company. The move comes as part of a bid to focus J&J’s medical technology division on faster-growing areas. In an Oct.
Thousands of claimants in the U.K. are suing Johnson & Johnson (NYSE:JNJ), accusing the healthcare giant of knowingly selling asbestos-contaminated talcum powder that allegedly caused cancer in ...
The New York Jets have agreed to a multi-year sponsorship with Johnson & Johnson to promote better health to Jets fans, making them the team's Official Medical Innovation Sponsor. Johnson & Johnson ...
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging people diagnosed with cancers were exposed to asbestos in its talcum powder, ...
Texas Attorney General Ken Paxton announced he is suing the makers of Tylenol, claiming the companies failed to warn consumers about the risks of taking the drug while pregnant. Paxton filed a lawsuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback